BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6218101)

  • 1. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results.
    Hellriegel KP; Kindler J; Wittenberg C; Kress M
    Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
    Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R; Rachlis A; Tuffnell PG; Duncan I; Moran L; Pinfold P; DeBoer G
    Arch Intern Med; 1984 May; 144(5):1005-10. PubMed ID: 6712393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
    Gucalp R; Lia S; McKitrick JC; Wiernik PH
    Am J Med; 1988 Jul; 85(1A):31-5. PubMed ID: 3041816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
    Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
    Infection; 1986; 14(6):261-7. PubMed ID: 3546144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
    Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
    Vandercam B; Ezzeddine H; Agaliotis D; Gala JL; Gigi J; Wauters G; Michaux JL
    Acta Clin Belg; 1989; 44(2):99-109. PubMed ID: 2800889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
    Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
    J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
    Martino P; Venditti M; Petti MC; Mandelli F; Serra P
    Infection; 1985; 13(3):125-9. PubMed ID: 3928495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
    Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
    Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Moody MR; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1980 Aug; 18(2):299-306. PubMed ID: 6449902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.
    Meunier F; Zinner SH; Gaya H; Calandra T; Viscoli C; Klastersky J; Glauser M
    Antimicrob Agents Chemother; 1991 May; 35(5):873-8. PubMed ID: 1854169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
    Santini G; Carella AM; Bacigalupo A; Van Lint MT; Congiu AM; Occhini D; Costa G; Sbaffi A; Accornero L; Sciutto C
    Tumori; 1984 Apr; 70(2):151-8. PubMed ID: 6328716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.